Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Utah Medical Products (UTMD) over the last 16 years, with Q3 2025 value amounting to $2.2 million.

  • Utah Medical Products' Net Cash Flow rose 29200.7% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.2 million, marking a year-over-year decrease of 178133.33%. This contributed to the annual value of -$9.2 million for FY2024, which is 15272.64% down from last year.
  • Per Utah Medical Products' latest filing, its Net Cash Flow stood at $2.2 million for Q3 2025, which was up 29200.7% from -$1.7 million recorded in Q2 2025.
  • Utah Medical Products' 5-year Net Cash Flow high stood at $5.8 million for Q1 2023, and its period low was -$4.8 million during Q4 2024.
  • Its 5-year average for Net Cash Flow is $1.8 million, with a median of $3.4 million in 2021.
  • In the last 5 years, Utah Medical Products' Net Cash Flow skyrocketed by 30790.91% in 2021 and then plummeted by 22679.32% in 2024.
  • Quarter analysis of 5 years shows Utah Medical Products' Net Cash Flow stood at -$3.3 million in 2021, then surged by 241.55% to $4.7 million in 2022, then decreased by 11.67% to $4.2 million in 2023, then tumbled by 215.54% to -$4.8 million in 2024, then soared by 145.86% to $2.2 million in 2025.
  • Its Net Cash Flow was $2.2 million in Q3 2025, compared to -$1.7 million in Q2 2025 and $42000.0 in Q1 2025.